Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab Versus LDL Apheresis in Hypercholesterolemia
NCT03429998Phase 3Completed
- Sponsor
- Gregorio Marañón University General Hospital
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of evolocumab in familial hypercholesterolemia (FH), sponsored by Gregorio Marañón University General Hospital. Started Apr 2017; status: completed.
02
Drugs
evolocumab
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT03429998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03429998.